Company Filing History:
Years Active: 1998-2005
Title: The Innovative Contributions of Renee Williard
Introduction
Renee Williard is a prominent inventor based in San Francisco, CA. She has made significant contributions to the field of biochemistry, particularly in the area of estrogenic activity. With a total of 3 patents to her name, her work has implications for both scientific research and potential therapeutic applications.
Latest Patents
One of her latest patents is titled "Methods for screening compounds for estrogenic activity." This invention provides novel assay methods for identifying compounds that may have both estrogen agonist and antagonist properties. The assay utilizes cells comprising promoters having an AP1 site linked to a reporter gene. Compounds capable of inducing or blocking expression of the reporter gene can thus be identified. Additionally, these compounds may be further tested for their ability to modulate the standard estrogen response.
Another significant patent is "Compositions comprising inhibitors of estrogen response." This work further emphasizes her focus on understanding and manipulating estrogenic activity, which is crucial for various health-related applications.
Career Highlights
Renee Williard is affiliated with the University of California, where she continues to advance her research and innovation. Her academic background and ongoing projects contribute to her reputation as a leading figure in her field.
Collaborations
Throughout her career, Renee has collaborated with notable colleagues, including Peter J. Kushner and Paul Webb. These partnerships have enhanced her research and expanded the impact of her inventions.
Conclusion
Renee Williard's innovative work in the field of estrogenic activity showcases her dedication to scientific advancement. Her patents not only reflect her expertise but also hold promise for future developments in health and medicine.